Skip Navigation

Journal of Tropical Pediatrics 1996 42(4):228-232; doi:10.1093/tropej/42.4.228
© 1996 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Soliman, A. T.
Right arrow Articles by Asfour, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soliman, A. T.
Right arrow Articles by Asfour, M. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

research-article

Growth Parameters, Growth Hormone (GH) Response to Clonidine and Circulating Insulin-like Growth Factor-I (IGF-I), Free Thyroxine (FT4) and Cortisol Concentrations in Relation to Glycaemic Control in Children with Insulin-Dependent Diabetes Mellitus

Ashraf T. Soliman, MD*,, Helmy I. Ahmed, MD** and Maurice G. Asfour, MD***

*Department of Pediatrics, WHO Collaborative Center, Royal Hospital Muscat, Oman
**Department of Endocrinology, WHO Collaborative Center, Royal Hospital Muscat, Oman
***Department of National Diabetes Center, WHO Collaborative Center, Royal Hospital Muscat, Oman

Correspondence: Ashraf T. Soliman, Chief, Pediatric Endocrinology, Royal Hospital, P.O. Box 1331 Seeb, Muscat, Sultanate of Oman

The objective of tins paper was to determine the effect of glycaemic control and endocrine functions on linear growth in children with IDDM.

We studied 45 prepubertal children with IDDM (30 males, 15 females) over 1 year period. The mean±SD for age of onset and duration of IDDM were 6.2±2.3 years and 3.5±1.3 years, respectively. At each clinic visit (every 3 months), glycaemic control was assessed by measuring glycosylated haemoglobin (HbA1C). Growth hormone and cortisol responses to high dose clonidine (0.15 mg/m2) and ACTH, respectively, were evaluated and circulating concentrations of free thyroxine (FT4) and TSH estimated. The average insulin dose (unit/kg/day) during this period was calculated for each patient. Growth was assessed by determining both height standard deviation score (HtSDS) and growth velocity standard deviation scores (GVSDS) and bone age determined according to the atlas of Greulich and Pyle. Two-hundred-and-fifty age- and sex-matched normal children served as controls for growth data, and 20 normal age-matched children and 20 normal children with short stature (NVSS) served as controls for the hormonal studies.

Growth velocity (GV) (cm/year) and GVSDS were significantly lower in children with IDDM compared to normal children, and significantly lower in children with poorly controlled diabetes compared to those with good glycaemic control. GV and GVSDS were inversely correlated to HbA1C (r=–0.356, P<0.01 and r=0335, P<0.01 respectively). GVSDS was correlated with serum IGF-I (r=0.22, P<0.01) FT4 (r=0321, P<0.01) and inversely with basal GH ( r=–0.362, P<0.01) concentrations, but was not correlated with cortisol levels or peak GH concentrations in response to clonidine. GVSDS was correlated with HtSDS (r=0.222, P<0.01) and inversely with age (r=–0.43, P0.05). There was no significant correlation between GVSDS on the one hand and weight gain or body mass index (BMI) on the other hand. Peak GH response to clonidine was correlated with BMI (r=0.68, P0.001) and insulin dose/kg/day (r=0.602, P0.01)

This study confirms that in children with IDDM linear growth velocity is dependent on the age of the child and the degree of glycaemic control, as well as on growth promoting hormones such as IGF-I and FT4. High BMI is associated with more GH secretion in response to clonidine, this might explain the higher requirements of insulin/kg in children with IDDM and high BML


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.